제대혈 은행 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Cord Blood Banking Market size is expected to reach USD 67.07 Billion in 2034 from USD 34.00 Billion (2025) growing at a CAGR of 7.84% during 2026-2034.

Cord blood banking is entering a growth phase as cellular therapies and regenerative medicine expand beyond hematologic applications into broader immunotherapies and tissue repair. Cord blood is a rich source of hematopoietic stem and progenitor cells used in transplant medicine and an emerging reservoir for cell-based interventions such as engineered immune cells and regenerative constructs. As clinical trials validate novel indications-ranging from autoimmune disorders to neonatal brain injury-demand for high-quality, cryopreserved cord blood units and companion biobanking services will rise. Strategic differentiation will hinge on unit quality, processing methods, and the ability to provide linked clinical data that enhances translational utility.

Process innovation and standardization are key competitive levers. Closed automated collection and processing platforms reduce contamination risk and ensure higher viable cell yields; standardized viability assays, potency metrics, and robust chain-of-custody systems bolster clinical confidence. Advanced cryopreservation protocols, optimized cryoprotectant chemistries, and controlled-rate freezing technologies improve long-term cell recovery, making banked units more reliable for later therapeutic use. Blockchain and secure digital records are being piloted to maintain provenance, consent, and linkage to maternal and neonatal health data-facilitating research while meeting regulatory expectations around data privacy.

Market growth will be shaped by regulatory frameworks and clinical evidence. As regulatory agencies clarify pathways for cell therapy products derived from cord blood, banks that adhere to GMP-grade processing and provide regulatory-ready documentation will capture institutional demand. Collaboration between cord blood banks, biotech companies, and hospitals will unlock translational pipelines where stored units become sources for autologous and allogeneic therapies. Geographic expansion into emerging markets-supported by localized accreditation and education campaigns-will broaden collection volumes. In parallel, hybrid service models offering public, private, and directed donation options will create flexible value propositions for families and health systems. Collectively, the cord blood banking sector is positioned to underpin a new generation of cellular therapeutics and personalized regenerative strategies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Collection & Transportation
• Processing
• Analysis
• Storage

By Bank

• Private
• Public
• Hybrid

By Component

• Cord Blood
• Cord Tissue

By Application

• Cancer
• Genetic Disorders
• Blood Disorders
• Immune Deficiencies
• Metabolic Disorders
• Other Applications

By End-use

• Hospitals
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes

COMPANIES PROFILED

• Global Cord Blood Corporation, CBR Systems Inc, CryoCell International, Cordlife Group Limited, AlphaCord LLC, CSGBIO, California Cryobank Stem Cell Services LLC, Cord Blood Foundation Smart Cells International, Singapore Cord Blood Bank, FamiCord
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CORD BLOOD BANKING MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Collection & Transportation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CORD BLOOD BANKING MARKET: BY BANK 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Bank
• 5.2. Private Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hybrid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CORD BLOOD BANKING MARKET: BY COMPONENT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Component
• 6.2. Cord Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cord Tissue Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CORD BLOOD BANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Genetic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Blood Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Immune Deficiencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Metabolic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CORD BLOOD BANKING MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL CORD BLOOD BANKING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Service
  • 9.2.2 By Bank
  • 9.2.3 By Component
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Service
  • 9.3.2 By Bank
  • 9.3.3 By Component
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Service
  • 9.4.2 By Bank
  • 9.4.3 By Component
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Service
  • 9.5.2 By Bank
  • 9.5.3 By Component
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Service
  • 9.6.2 By Bank
  • 9.6.3 By Component
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL CORD BLOOD BANKING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Global Cord Blood Corporation
  • 11.2.2 CBR Systems Inc
  • 11.2.3 Cryo-Cell International
  • 11.2.4 Cordlife Group Limited
  • 11.2.5 AlphaCord LLC
  • 11.2.6 CSG-BIO
  • 11.2.7 California Cryobank Stem Cell Services LLC
  • 11.2.8 Cord Blood Foundation (Smart Cells International)
  • 11.2.9 Singapore Cord Blood Bank
  • 11.2.10 FamiCord